EUVIMEDEUVIMED entdecken
Systematische Übersicht

Systematic literature review to inform the Portuguese recommendations for the management of Raynaud’s phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases

Emanuel Costa, Filipe Cunha-Santos, Eduardo Dourado, Daniela Oliveira, Louise Falzon, Vasco Romão, Ana Catarina Duarte, Ana Cordeiro, Tânia Santiago, Alexandre Sepriano

ARP Rheumatology · 2024

DOI: 10.63032/yhbl8967 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift ARP Rheumatology, 2024. Verfasst von Emanuel Costa und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hospital de Braga, Braga, Portugal. Hauptthemen laut MEDLINE: Raynaud Disease, Scleroderma, Systemic, Connective Tissue Diseases, Skin Ulcer. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 111 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To perform a systematic literature review (SLR) aimed at evaluating the efficacy and safety of pharmacological and non-pharmacological treatments for Raynaud's phenomenon (RP) and digital ulcers (DU) in patients with systemic sclerosis (SSc) and other connective tissue diseases (CTD), in order to inform the Portuguese recommendations for managing RP and DU in these patients.

Methods

A SLR was conducted until May 2022 to identify studies assessing the efficacy and safety of pharmacological and non-pharmacological interventions for RP and DU in SSc and other CTD. Eligible study designs included randomized controlled trials (RCTs), controlled clinical trials, and their extensions for assessing efficacy and safety of interventions. Observational studies with a comparator were included for evaluating the efficacy and safety of non-pharmacological interventions and safety of pharmacological interventions. The risk of bias of each study was assessed using standard tools.

Results

Out of 71 publications meeting the inclusion criteria, 59 evaluated pharmacological and 12 non-pharmacological interventions. We found moderate quality evidence supporting the efficacy of calcium channel blockers, phosphodiesterase-5 inhibitors, and intravenous prostacyclin analogues in reducing RP frequency, severity, and duration. Intravenous iloprost had a small to moderate effect size in improving DU healing. Phosphodiesterase-5 inhibitors were effective in reducing total DU count, new DU occurrence, and enhancing DU healing. Bosentan effectively prevented new DU in SSc patients. No new safety concerns were associated with these treatments. The studies on non-pharmacological interventions were, in general, of low quality, and had a small sample size. Warming measures decreased frequency and duration of RP attacks; laser therapy improved RP-related outcomes; local oxygen-ozone therapy improved RP outcomes as an add-on therapy; bone marrow mononuclear cell implantation improved DU-associated pain; periarterial sympathectomy and vascular bypass reduced DU number and finger amputation risk.

Conclusion

The available evidence supports the efficacy and safety of pharmacological interventions, namely nifedipine, sildenafil, iloprost, and bosentan in treating RP and DU in patients with SSc and other CTD. Scarce and low-quality evidence does support the use of some non-pharmacological interventions but with only a modest effect size. This SLR underscores the limited availability of high-quality evidence for determining the optimal treatment of RP and/or DUs, emphasising the need for further studies to evaluate efficacy and safety aspects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Raynaud DiseaseScleroderma, SystemicConnective Tissue DiseasesSkin UlcerHumansPortugalCalcium Channel BlockersFingersPractice Guidelines as TopicIloprostPhosphodiesterase 5 InhibitorsVasodilator Agents

Substanzen

Calcium Channel BlockersIloprostPhosphodiesterase 5 InhibitorsVasodilator Agents

Autor:innen und Institutionen

  • Hospital de Braga, Braga, Portugal.
  • Unidade Local de Saúde da Guarda, Guarda, Portugal.
  • Centro Hospitalar do Baixo Vouga, Aveiro, Portugal.
  • Centro Hospitalar Universitário de São João, Porto, Portugal.
  • University of Sheffield, Sheffield, United Kingdom.
  • Centro Hospitalar Universitário Lisboa Norte, Centro Académico de Medicina de Lisboa, Lisbon, Portugal.

Zitieren

APA

Costa, E., Cunha-Santos, F., Dourado, E., Oliveira, D., Falzon, L., Romão, V., Duarte, A. C., Cordeiro, A., Santiago, T., & Sepriano, A. (2024). Systematic literature review to inform the Portuguese recommendations for the management of Raynaud’s phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases. ARP Rheumatology. https://doi.org/10.63032/yhbl8967

Vancouver

Costa E, Cunha-Santos F, Dourado E, Oliveira D, Falzon L, Romão V, et al. Systematic literature review to inform the Portuguese recommendations for the management of Raynaud’s phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases. ARP Rheumatology. 2024. doi:10.63032/yhbl8967

BibTeX
@article{Costa2024,
  author = {Costa, Emanuel and Cunha-Santos, Filipe and Dourado, Eduardo and Oliveira, Daniela and Falzon, Louise and Romão, Vasco and Duarte, Ana Catarina and Cordeiro, Ana and Santiago, Tânia and Sepriano, Alexandre},
  title = {Systematic literature review to inform the Portuguese recommendations for the management of Raynaud’s phenomenon and digital ulcers in systemic sclerosis and other connective tissue diseases},
  journal = {ARP Rheumatology},
  year = {2024},
  doi = {10.63032/yhbl8967}
}
Kostenlos starten →